Bluejay Investor Presentation Deck

IL-6 is Following a Well-Established Clinical Testing Pathway Studies will document SymphonyTM performance versus standard of care Milestone Initial Testing Program at UT Southwestern Medical Center File FDA Pre-submission application Initial Clinical Trials Expansion of Clinical Trial Program File De Novo Marketing Application with FDA Commercial Launch 00 bluejay DIAGNOSTICS Timing Q4 2021: Complete January 2022: Complete Q3 2022: Complete Q4 2022 1H 2023 1H 2024 Copyright ©2022 Bluejay Diagnostics, Inc. All rights reserved in all slides | October 2022 9

View entire presentation